Items where Author is "Rasenack, M."
Number of items: 8. 2018Hanssen, H. and Minghetti, A. and Magon, S. and Rossmeissl, A. and Rasenack, M. and Papadopoulou, A. and Klenk, C. and Faude, O. and Zahner, L. and Sprenger, T. and Donath, L.. (2018) Effects of different endurance exercise modalities on migraine days and cerebrovascular health in episodic migraineurs: A randomized controlled trial. Scandinavian journal of medicine & science in sports, 28 (3). pp. 1103-1112. 2016Rasenack, M. and Derfuss, T.. (2016) Disease activity return after natalizumab cessation in multiple sclerosis. Expert Review of Neurotherapeutics, 16 (5). pp. 587-594. Rasenack, M. and Rychen, J. and Andelova, M. and Naegelin, Y. and Stippich, C. and Kappos, L. and Lindberg, R. L. and Sprenger, T. and Derfuss, T.. (2016) Efficacy and Safety of Fingolimod in an Unselected Patient Population. PLoS One, 11 (1). e0146190. Athanasopoulou, I. M. and Rasenack, M. and Grimm, C. and Axer, H. and Sinnreich, M. and Decard, B. F. and Grimm, A.. (2016) Ultrasound of the nerves — An appropriate addition to nerve conduction studies to differentiate paraproteinemic neuropathies. Journal of the Neurological Sciences, 362. pp. 188-195. 2015Derfuss, T. and Curtin, F. and Guebelin, C. and Bridel, C. and Rasenack, M. and Matthey, A. and Du Pasquier, R. and Schluep, M. and Desmeules, J. and Lang, A. B. and Perron, H. and Faucard, R. and Porchet, H. and Hartung, H. P. and Kappos, L. and Lalive, P. H.. (2015) A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients. Multiple Sclerosis Journal, 21 (7). pp. 885-893. Derfuss, T. and Curtin, F. and Guebelin, C. and Bridel, C. and Rasenack, M. and Matthey, A. and Du Pasquier, R. and Schluep, M. and Desmeules, J. and Lang, A. B. and Perron, H. and Faucard, R. and Porchet, H. and Hartung, H. P. and Kappos, L. and Lalive, P. H.. (2015) A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up. Journal of Neuroimmunology, 285. pp. 68-70. 2012Penner, I. -K. and Hubacher, M. and Rasenack, M. and Sprenger, T. and Weber, P. and Naegelin, Y.. (2012) Cognitive relapse in the absence of new neurological symptoms : clinical utility of neuropsychological assessment in a case with juvenile multiple sclerosis. Multiple sclerosis journal, Vol. 18, H. 4. p. 303. Penner, I. K. and Hubacher, M. and Rasenack, M. and Sprenger, T. and Weber, P. and Naegelin, Y.. (2012) Utility of neuropsychological testing for guiding treatment decisions in paediatric multiple sclerosis. Multiple sclerosis journal, Vol. 19, H. 3. pp. 366-368. |
